Synektik S.A. Logo

Synektik S.A.

Manufactures radiopharma; provides medical equipment, IT solutions, and services to specialists.

SNT | WAR

Overview

Corporate Details

ISIN(s):
PLSNKTK00019
LEI:
259400U0O19JWLVHQN14
Country:
Poland
Address:
WARSZAWA JÓZEFA PIUSA DZIEKOŃSKIEGO 3, 00-728 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Synektik S.A. is a provider and integrator of innovative solutions for the medical sector, with a focus on radiology, oncology, cardiology, and neurology. The company's core operations include the manufacturing of radiopharmaceuticals, the supply and service of advanced medical equipment, and the development of specialized IT solutions. Synektik supports medical facilities with products and services used in diagnostic imaging, nuclear medicine, and surgery, aiming to implement and disseminate modern medical technologies. The company also provides comprehensive maintenance for medical devices and IT infrastructure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-18 08:39
Regulatory News Service
Śródroczne skrócone skonsolidowane sprawozdanie finansowe za 4 kw. 2024
Polish 1.3 MB
2025-11-18 08:39
Regulatory News Service
wybrane dane finansowe za 4 kw. 2024
Polish 204.6 KB
2025-10-28 09:40
Report Publication Announcement
Terminy publikacji raportów okresowych - Content (PL)
Polish 2.0 KB
2025-10-27 15:29
Major Shareholding Notification
Zawiadomienie
Polish 83.0 KB
2025-10-27 15:29
Major Shareholding Notification
Otrzymanie zawiadomienia w trybie art. 69 ustawy o ofercie publicznej - zmiana …
Polish 1.7 KB
2025-10-27 12:52
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-23 12:37
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-21 08:51
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.6 KB
2025-10-20 10:43
Regulatory News Service
Temat: Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - C…
Polish 1.8 KB
2025-10-14 14:39
Related Party Transaction
Informacja o zawarciu istotnej umowy sprzedaży - Content (PL)
Polish 1.3 KB
2025-10-09 09:16
Regulatory News Service
Wybrane dane operacyjne segmentu sprzedaży sprzętu, rozwiązań IT oraz usług - C…
Polish 1.4 KB
2025-09-29 13:34
Regulatory News Service
Informacja o zawarciu istotnej umowy sprzedaży systemu robotycznego - Content (…
Polish 1.7 KB
2025-09-23 14:05
Board/Management Information
życiorys nowego Członka Zarządu
Polish 92.3 KB
2025-09-23 14:05
Board/Management Information
Powołanie nowego Członka Zarządu - Content (PL)
Polish 1.2 KB
2025-09-16 16:47
Related Party Transaction
Uzupełnienie informacji o zawarciu istotnej umowy sprzedaży systemu robotyczneg…
Polish 1.3 KB

Automate Your Workflow. Get a real-time feed of all Synektik S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Synektik S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Synektik S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden
ECTIN B
Edesa Biotech, Inc. Logo
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
United States of America
EDSA
Edgewise Therapeutics, Inc. Logo
Developing novel therapeutics for rare and serious muscle disorders.
United States of America
EWTX
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America
EDIT
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland
EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden
EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan
4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan
4523
Elanco Animal Health Inc Logo
Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.
United States of America
ELAN
Eledon Pharmaceuticals, Inc. Logo
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
United States of America
ELDN

Talk to a Data Expert

Have a question? We'll get back to you promptly.